Page last updated: 2024-10-18

glycine and Colonic Neoplasms

glycine has been researched along with Colonic Neoplasms in 35 studies

Colonic Neoplasms: Tumors or cancer of the COLON.

Research Excerpts

ExcerptRelevanceReference
" Here, we evaluated the anti-inflammatory Trimethylglycine and the Signal transducer and activator of transcription (STAT6) inhibitor AS1517499, as possible adjuvants to 5-FU in already established cancers, using a model of colitis-associated colon cancer (CAC)."7.96Use of STAT6 Phosphorylation Inhibitor and Trimethylglycine as New Adjuvant Therapies for 5-Fluorouracil in Colitis-Associated Tumorigenesis. ( Beristain-Terrazas, DL; Callejas, BE; Chirino, YI; Delgado-Buenrostro, NL; García-Castillo, V; Gutierrez-Cirlos, EB; León-Cabrera, SA; Mendoza-Rodríguez, MG; Meraz-Ríos, MA; Pérez-Plasencia, C; Rodríguez-Sosa, M; Sánchez-Barrera, CÁ; Terrazas, LI; Vaca-Paniagua, F, 2020)
"alpha-Methylacyl-CoA racemase (AMACR), an enzyme involved in oxidation of branched chain fatty acids and cholesterol metabolites, as well as ibuprofen metabolism, is overexpressed in colorectal adenomas and cancer."5.12Variants in the alpha-Methylacyl-CoA racemase gene and the association with advanced distal colorectal adenoma. ( Chatterjee, N; Daugherty, SE; Fallin, MD; Hayes, RB; Huang, WY; Isaacs, WB; Platz, EA; Shugart, YY; Welch, R, 2007)
" Here, we evaluated the anti-inflammatory Trimethylglycine and the Signal transducer and activator of transcription (STAT6) inhibitor AS1517499, as possible adjuvants to 5-FU in already established cancers, using a model of colitis-associated colon cancer (CAC)."3.96Use of STAT6 Phosphorylation Inhibitor and Trimethylglycine as New Adjuvant Therapies for 5-Fluorouracil in Colitis-Associated Tumorigenesis. ( Beristain-Terrazas, DL; Callejas, BE; Chirino, YI; Delgado-Buenrostro, NL; García-Castillo, V; Gutierrez-Cirlos, EB; León-Cabrera, SA; Mendoza-Rodríguez, MG; Meraz-Ríos, MA; Pérez-Plasencia, C; Rodríguez-Sosa, M; Sánchez-Barrera, CÁ; Terrazas, LI; Vaca-Paniagua, F, 2020)
"HCT-116 colon cancer xenografts lacking mitochondrial 1C pathway activity generate the 1C units required for growth by cytosolic serine catabolism."1.43Reversal of Cytosolic One-Carbon Flux Compensates for Loss of the Mitochondrial Folate Pathway. ( Chen, L; Ducker, GS; Esposito, M; Ghergurovich, JM; Kang, Y; Morscher, RJ; Rabinowitz, JD; Teng, X, 2016)
"Ixazomib treatment resulted in significant metabolic regulation, and some of these changes were specific to KRAS WT tumors."1.42KRAS Genotype Correlates with Proteasome Inhibitor Ixazomib Activity in Preclinical In Vivo Models of Colon and Non-Small Cell Lung Cancer: Potential Role of Tumor Metabolism. ( Amidon, B; Bannerman, B; Berger, AJ; Bernard, H; Chattopadhyay, N; Donelan, J; Galvin, K; Garnsey, J; Hales, P; Hather, G; Jordan, K; Koenig, E; Maldonado Lopez, A; Manfredi, M; Rhodes, N; Stringer, B; Tirrell, S; Xia, C; Yang, Y, 2015)
"The in vivo anticancer activity study with HT-29 colon cancer cell xenografted mice showed that the intratumorally injected PCC hydrogel inhibited the tumor growth more effectively relative to CPT alone (-29% vs."1.38Injectable poly(organophosphazene)-camptothecin conjugate hydrogels: synthesis, characterization, and antitumor activities. ( Cho, JK; Chun, C; Kuh, HJ; Song, SC, 2012)
"In two ulcerative colitis patients, a mutation was found in the Ki-ras gene (Gly --> Asp 12 and Gly --> Val 12), and in one patient, a mutation in exon 5 of the p53 gene."1.30Detection of Ki-ras mutations by PCR and differential hybridization and of p53 mutations by SSCP analysis in endoscopically obtained lavage solution from patients with long-standing ulcerative colitis. ( Heinzlmann, M; Lang, SM; Loeschke, K; Stratakis, DF; Teschauer, W, 1997)

Research

Studies (35)

TimeframeStudies, this research(%)All Research%
pre-19905 (14.29)18.7374
1990's9 (25.71)18.2507
2000's8 (22.86)29.6817
2010's12 (34.29)24.3611
2020's1 (2.86)2.80

Authors

AuthorsStudies
Mendoza-Rodríguez, MG1
Sánchez-Barrera, CÁ1
Callejas, BE1
García-Castillo, V1
Beristain-Terrazas, DL1
Delgado-Buenrostro, NL1
Chirino, YI1
León-Cabrera, SA1
Rodríguez-Sosa, M1
Gutierrez-Cirlos, EB1
Pérez-Plasencia, C1
Vaca-Paniagua, F1
Meraz-Ríos, MA1
Terrazas, LI1
Engür, S1
Dikmen, M1
Farhangian, H1
Eslami Moghadam, M1
Divsalar, A1
Rahiminezhad, A1
Zhao, Y1
Wu, Z1
Zhang, Y1
Zhu, L1
Gonsalves, WI1
Mahoney, MR1
Sargent, DJ1
Nelson, GD1
Alberts, SR1
Sinicrope, FA1
Goldberg, RM1
Limburg, PJ1
Thibodeau, SN1
Grothey, A1
Hubbard, JM1
Chan, E1
Nair, S1
Berenberg, JL1
McWilliams, RR1
Rocha, C1
Papon, L1
Cacheux, W1
Marques Sousa, P1
Lascano, V1
Tort, O1
Giordano, T1
Vacher, S1
Lemmers, B1
Mariani, P1
Meseure, D1
Medema, JP1
Bièche, I1
Hahne, M1
Janke, C1
Fan, K1
Li, N1
Qi, J1
Yin, P1
Zhao, C1
Wang, L1
Li, Z1
Zha, X1
Chattopadhyay, N1
Berger, AJ1
Koenig, E1
Bannerman, B1
Garnsey, J1
Bernard, H1
Hales, P1
Maldonado Lopez, A1
Yang, Y1
Donelan, J1
Jordan, K1
Tirrell, S1
Stringer, B1
Xia, C1
Hather, G1
Galvin, K1
Manfredi, M1
Rhodes, N1
Amidon, B1
Ducker, GS1
Chen, L1
Morscher, RJ1
Ghergurovich, JM1
Esposito, M1
Teng, X1
Kang, Y1
Rabinowitz, JD1
Riscal, R1
Schrepfer, E1
Arena, G1
Cissé, MY1
Bellvert, F1
Heuillet, M1
Rambow, F1
Bonneil, E1
Sabourdy, F1
Vincent, C1
Ait-Arsa, I1
Levade, T1
Thibaut, P1
Marine, JC1
Portais, JC1
Sarry, JE1
Le Cam, L1
Linares, LK1
Liu, Y1
Wang, SQ1
Long, YH1
Chen, S1
Li, YF1
Zhang, JH1
Li, Y1
Tan, T1
Zheng, J1
Zhang, C1
Cho, JK1
Chun, C1
Kuh, HJ1
Song, SC1
Duan, X1
Li, H1
Chen, H1
Wang, Q1
Gross, I1
Lhermitte, B1
Domon-Dell, C1
Duluc, I1
Martin, E1
Gaiddon, C1
Kedinger, M1
Freund, JN1
Houli, N1
Loh, SW1
Giraud, AS1
Baldwin, GS2
Shulkes, A2
Chattopadhyay, S1
Zhao, R1
Krupenko, SA1
Krupenko, N1
Goldman, ID1
Arakawa, Y1
Suzuki, H1
Saito, S1
Yamada, H1
Daugherty, SE1
Platz, EA1
Shugart, YY1
Fallin, MD1
Isaacs, WB1
Chatterjee, N1
Welch, R1
Huang, WY1
Hayes, RB1
Wilson, KJ1
Witter, DJ1
Grimm, JB1
Siliphaivanh, P1
Otte, KM1
Kral, AM1
Fleming, JC1
Harsch, A1
Hamill, JE1
Cruz, JC1
Chenard, M1
Szewczak, AA1
Middleton, RE1
Hughes, BL1
Dahlberg, WK1
Secrist, JP1
Miller, TA1
Claque, MB1
Carmichael, MJ1
Satoh, M1
Cherian, MG1
Imura, N1
Shimizu, H1
Gan, LS1
Niederer, T1
Eads, C1
Thakker, D1
Capaccioli, S1
Di Pasquale, G1
Mini, E1
Mazzei, T1
Quattrone, A1
Furuishi, K1
Misumi, S1
Shoji, S1
Lang, SM1
Heinzlmann, M1
Stratakis, DF1
Teschauer, W1
Loeschke, K1
Hofman, P1
Selva, E1
Le Negrate, G1
d'Andrea, L1
Guérin, S1
Rossi, B1
Auberger, P1
Paranavitana, CM1
Lozonschi, L1
Sunamura, M1
Kobari, M1
Egawa, S1
Ding, L1
Matsuno, S1
Aly, A1
Saravis, CA2
Oh, SK2
Pusztaszeri, G2
Doos, WG1
Zamcheck, N2
Doos, W1
Smith, TK1
Gibson, CL1
Howlin, BJ1
Pratt, JM1
Striebel, JP1
Saeger, HD1
Ritz, R1
Leweling, H1
Holm, E1
Bibby, MC1
Double, JA1

Trials

1 trial available for glycine and Colonic Neoplasms

ArticleYear
Variants in the alpha-Methylacyl-CoA racemase gene and the association with advanced distal colorectal adenoma.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2007, Volume: 16, Issue:8

    Topics: Adenoma; Aged; Alleles; Anti-Inflammatory Agents, Non-Steroidal; Aspartic Acid; Case-Control Studies

2007

Other Studies

34 other studies available for glycine and Colonic Neoplasms

ArticleYear
Use of STAT6 Phosphorylation Inhibitor and Trimethylglycine as New Adjuvant Therapies for 5-Fluorouracil in Colitis-Associated Tumorigenesis.
    International journal of molecular sciences, 2020, Mar-20, Volume: 21, Issue:6

    Topics: Adjuvants, Pharmaceutic; Animals; Apoptosis; beta Catenin; Cadherins; Carcinogenesis; Cell Adhesion

2020
The evaluation of the anti-cancer activity of ixazomib on Caco2 colon solid tumor cells, comparison with bortezomib.
    Acta clinica Belgica, 2017, Volume: 72, Issue:6

    Topics: Adenocarcinoma; Antineoplastic Agents; Boron Compounds; Bortezomib; Caco-2 Cells; Caspase 3; Colonic

2017
Anticancer activity of novel amino acid derivative of palladium complex with phendione ligand against of human colon cancer cell line.
    Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry, 2017, Volume: 22, Issue:7

    Topics: Animals; Antineoplastic Agents; Cattle; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Coo

2017
HY-1 induces G(2)/M cell cycle arrest in human colon cancer cells through the ATR-Chk1-Cdc25C and Weel pathways.
    Cancer science, 2013, Volume: 104, Issue:8

    Topics: Animals; Apoptosis; Ataxia Telangiectasia Mutated Proteins; CDC2 Protein Kinase; cdc25 Phosphatases;

2013
Patient and tumor characteristics and BRAF and KRAS mutations in colon cancer, NCCTG/Alliance N0147.
    Journal of the National Cancer Institute, 2014, Volume: 106, Issue:7

    Topics: Adult; Aged; Aspartic Acid; Clinical Trials, Phase III as Topic; Colonic Neoplasms; DNA Mismatch Rep

2014
Tubulin glycylases are required for primary cilia, control of cell proliferation and tumor development in colon.
    The EMBO journal, 2014, Oct-01, Volume: 33, Issue:19

    Topics: Animals; Blotting, Western; Carcinogens; Cell Proliferation; Cells, Cultured; Cilia; Colon; Colonic

2014
Wnt/β-catenin signaling induces the transcription of cystathionine-γ-lyase, a stimulator of tumor in colon cancer.
    Cellular signalling, 2014, Volume: 26, Issue:12

    Topics: Alkynes; Animals; Binding Sites; Cell Line, Tumor; Cell Movement; Cell Proliferation; Colonic Neopla

2014
KRAS Genotype Correlates with Proteasome Inhibitor Ixazomib Activity in Preclinical In Vivo Models of Colon and Non-Small Cell Lung Cancer: Potential Role of Tumor Metabolism.
    PloS one, 2015, Volume: 10, Issue:12

    Topics: Amino Acids; Animals; Antineoplastic Agents; Boron Compounds; Carcinoma, Non-Small-Cell Lung; Cell L

2015
Reversal of Cytosolic One-Carbon Flux Compensates for Loss of the Mitochondrial Folate Pathway.
    Cell metabolism, 2016, 06-14, Volume: 23, Issue:6

    Topics: Aminoimidazole Carboxamide; Carbon; Cell Compartmentation; Cell Proliferation; Colonic Neoplasms; CR

2016
Chromatin-Bound MDM2 Regulates Serine Metabolism and Redox Homeostasis Independently of p53.
    Molecular cell, 2016, 06-16, Volume: 62, Issue:6

    Topics: Activating Transcription Factor 4; Animals; Carcinoma, Non-Small-Cell Lung; Carrier Proteins; Cell P

2016
KRASG12 mutant induces the release of the WSTF/NRG3 complex, and contributes to an oncogenic paracrine signaling pathway.
    Oncotarget, 2016, Aug-16, Volume: 7, Issue:33

    Topics: A549 Cells; Animals; Antineoplastic Agents, Immunological; Cell Line; Cell Line, Tumor; Cell Prolife

2016
[A comparison on radiochemical behavior and biological property of antisense oligonucleotide labeled with technetium-99m by two methods: NHS-MAG3 versus SHNHP].
    Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi, 2008, Volume: 25, Issue:4

    Topics: Animals; Colonic Neoplasms; Glycine; Humans; Isotope Labeling; Mice; Mice, Inbred BALB C; Niacinamid

2008
Injectable poly(organophosphazene)-camptothecin conjugate hydrogels: synthesis, characterization, and antitumor activities.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2012, Volume: 81, Issue:3

    Topics: Animals; Antineoplastic Agents; Camptothecin; Cell Line, Tumor; Colonic Neoplasms; Drug Stability; D

2012
Discrimination of colon cancer stem cells using noncanonical amino acid.
    Chemical communications (Cambridge, England), 2012, Sep-18, Volume: 48, Issue:72

    Topics: Alkynes; Cell Separation; Colonic Neoplasms; Glycine; HCT116 Cells; Humans; Neoplastic Stem Cells

2012
Phosphorylation of the homeotic tumor suppressor Cdx2 mediates its ubiquitin-dependent proteasome degradation.
    Oncogene, 2005, Dec-01, Volume: 24, Issue:54

    Topics: Adenocarcinoma; Alanine; Alkaline Phosphatase; Amino Acid Sequence; Amino Acid Substitution; Animals

2005
Mitogenic effects of both amidated and glycine-extended gastrin-releasing peptide in defunctioned and azoxymethane-treated rat colon in vivo.
    Regulatory peptides, 2006, Mar-15, Volume: 134, Issue:1

    Topics: Animals; Azoxymethane; Cell Proliferation; Colon; Colonic Neoplasms; Gastrin-Releasing Peptide; Glyc

2006
The inverse relationship between reduced folate carrier function and pemetrexed activity in a human colon cancer cell line.
    Molecular cancer therapeutics, 2006, Volume: 5, Issue:2

    Topics: Amino Acid Substitution; Antineoplastic Agents; Arginine; Carrier Proteins; Cell Line, Tumor; Coloni

2006
Novel missense mutation of the DNA topoisomerase I gene in SN-38-resistant DLD-1 cells.
    Molecular cancer therapeutics, 2006, Volume: 5, Issue:3

    Topics: Amino Acid Substitution; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Line, Tumor; Colonic

2006
Phenylglycine and phenylalanine derivatives as potent and selective HDAC1 inhibitors (SHI-1).
    Bioorganic & medicinal chemistry letters, 2008, Mar-15, Volume: 18, Issue:6

    Topics: Acetylation; Amides; Animals; Cell Proliferation; Colonic Neoplasms; Dogs; Enzyme Inhibitors; ERG1 P

2008
15N glycine metabolism.
    Annals of surgery, 1982, Volume: 195, Issue:4

    Topics: Colonic Neoplasms; Glycine; Humans; Kinetics; Rectal Neoplasms

1982
Modulation of resistance to anticancer drugs by inhibition of metallothionein synthesis.
    Cancer research, 1994, Oct-15, Volume: 54, Issue:20

    Topics: Alkynes; Animals; Cisplatin; Colonic Neoplasms; Cysteine; Doxorubicin; Drug Resistance; Female; Fibr

1994
Evidence for predominantly paracellular transport of thyrotropin-releasing hormone across CACO-2 cell monolayers.
    Biochemical and biophysical research communications, 1993, Dec-15, Volume: 197, Issue:2

    Topics: 2,4-Dinitrophenol; Adenocarcinoma; Amiloride; Azides; Biological Transport; Cell Line; Cell Membrane

1993
Cationic lipids improve antisense oligonucleotide uptake and prevent degradation in cultured cells and in human serum.
    Biochemical and biophysical research communications, 1993, Dec-15, Volume: 197, Issue:2

    Topics: 3T3 Cells; Adenocarcinoma; Animals; Base Sequence; Biological Transport; Cell Line; Colonic Neoplasm

1993
A novel monoclonal antibody to N-myristoyl glycine moiety found a new N-myristoylated HIV-1 p28gag protein in HIV-1-infected cells.
    Biochemical and biophysical research communications, 1996, May-15, Volume: 222, Issue:2

    Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Antibody Specificity; Avian Sarcoma Viruses; Cells,

1996
Detection of Ki-ras mutations by PCR and differential hybridization and of p53 mutations by SSCP analysis in endoscopically obtained lavage solution from patients with long-standing ulcerative colitis.
    The American journal of gastroenterology, 1997, Volume: 92, Issue:12

    Topics: Aspartic Acid; Biopsy; Case-Control Studies; Cell Transformation, Neoplastic; Codon; Colitis, Ulcera

1997
CD10 inhibitors increase f-Met-Leu-Phe-induced neutrophil transmigration.
    Journal of leukocyte biology, 1998, Volume: 63, Issue:3

    Topics: Benzylidene Compounds; Chemotaxis, Leukocyte; Colonic Neoplasms; Drug Synergism; Enzyme Inhibitors;

1998
Non-radioactive detection of K-ras mutations by nested allele specific PCR and oligonucleotide hybridization.
    Molecular and cellular probes, 1998, Volume: 12, Issue:5

    Topics: Alanine; Amino Acid Substitution; Animals; Aspartic Acid; Breast Neoplasms; Codon; Colonic Neoplasms

1998
Controlling tumor angiogenesis and metastasis of C26 murine colon adenocarcinoma by a new matrix metalloproteinase inhibitor, KB-R7785, in two tumor models.
    Cancer research, 1999, Mar-15, Volume: 59, Issue:6

    Topics: Adenocarcinoma; Animals; Colonic Neoplasms; Glycine; Hydroxamic Acids; Lung Neoplasms; Male; Metallo

1999
Short term infusion of glycine-extended gastrin(17) stimulates both proliferation and formation of aberrant crypt foci in rat colonic mucosa.
    International journal of cancer, 2001, Nov-01, Volume: 94, Issue:3

    Topics: Animals; Azoxymethane; Carcinogens; Cell Division; Colon; Colonic Neoplasms; Gastrins; Glycine; Horm

2001
Tissue localization of zinc glycinate marker and carcinoembryonic antigen by immunofluorescence. I. Preparation of antisera against the zinc glycinate marker.
    Journal of the National Cancer Institute, 1978, Volume: 60, Issue:6

    Topics: Animals; Antibodies, Neoplasm; Carcinoembryonic Antigen; Chromatography, Gel; Colonic Neoplasms; Ele

1978
Present status of the zinc glycinate marker (ZGM).
    Cancer, 1978, Volume: 42, Issue:3 Suppl

    Topics: Antigens, Neoplasm; Chromatography, Gel; Colonic Neoplasms; Glycine; Humans; Neoplasm Metastasis; Ne

1978
Active transport of amino acids by gamma-glutamyl transpeptidase through Caco-2 cell monolayers.
    Biochemical and biophysical research communications, 1991, Aug-15, Volume: 178, Issue:3

    Topics: Amino Acids; Biological Transport; Biological Transport, Active; Cell Line; Cell Membrane; Colonic N

1991
[Amino acid uptake and release by colorectal cancer in man].
    Infusionstherapie und klinische Ernahrung, 1986, Volume: 13, Issue:2

    Topics: Aged; Amino Acids; Colonic Neoplasms; Female; Glutamates; Glutamic Acid; Glutamine; Glycine; Humans;

1986
Activity of N-[N'-(2-chloroethyl)-N'-nitrosocarbamoyl]-alanine and derivatives against transplantable adenocarcinomata of the mouse colon (MAC).
    Journal of cancer research and clinical oncology, 1986, Volume: 112, Issue:1

    Topics: 1,2-Dimethylhydrazine; Adenocarcinoma; Alanine; Animals; Antineoplastic Agents; Colonic Neoplasms; D

1986